Prediction of chronic lung allograft dysfunction: A systems medicine challenge

European Respiratory Journal

Volumn 43, Issue 3, 2014, Pages 689-693

  Pison, Christophe ^a,b,c,d   Magnan, Antoine ^e,f   Botturi, Karine ^e,f   Sève, Michel ^c,g   Brouard, Sophie ^e,f   Marsland, Benjamin J ^h,i   Ernst, Florian ^j   Paprotka, Tobias ^j   Deplanche, Kevin ^k   Fritz, Andreas ^l   Siroux, Valerie ^c   Boissel, Jean Pierre ^m   Corris, Paul A ⁿ   Auffray, Charles ^o   Nicod, Laurent P ^h,i  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Inserm1055   (France)

^c UNIV GRENOBLE ALPES   (France)

^d European Institute for Systems Biology and Medicine EISBM   (France)

^e L INSTITUT DU THORAX   (France)

^f UNIVERSITÉ DE NANTES   (France)

^g Prométhée Proteomics Platform   (France)

^h LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁱ UNIVERSITY OF LAUSANNE   (Switzerland)

^j GATC Biotech AG   (Germany)

^k Finovatis   (France)

^l Biomax Informatics AG   (Germany)

^m Novadiscovery   (France)

ⁿ NEWCASTLE UNIVERSITY   (United Kingdom)

^o UNIVERSITÉ DE LYON   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; MICRORNA;

AIR POLLUTION; BRONCHIOLITIS OBLITERANS; CHRONIC LUNG ALLOGRAFT DYSFUNCTION; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENOTYPE; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMS BIOLOGY;

ALGORITHMS; ALLOGRAFTS; BRONCHIOLITIS OBLITERANS; CHRONIC DISEASE; COMPUTER SIMULATION; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; PHENOTYPE; PRIMARY GRAFT DYSFUNCTION; PULMONARY MEDICINE; RESPIRATORY INSUFFICIENCY; SYSTEMS THEORY; TREATMENT OUTCOME;

EID: 84895536862     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00161313     Document Type: Review

References (15)

1. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012; 31: 1073-1086.
2. Sato M, Waddell TK, Wagnetz U, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30: 735-742.
3. Verleden GM, Raghu G, Meyer KC, et al. A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant 2013 [In press DOI: 10.1016/j.healun.2013.10.022].
4. Wolfe RA, Roys EC, Merion RM. Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant 2010; 10: 961-972.
5. Roedder S, Vitalone M, Khatri P, et al. Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med 2011; 3: 37.
6. Roedder S, Kimura N, Okamura H, et al. Significance and suppression of redundant IL17 responses in acute allograft rejection by bioinformatics based drug repositioning of fenofibrate. PLoS One 2013; 8: e56657.
7. Goldfarb-Rumyantzev AS. Personalised medicine, prediction of outcome in kidney transplant. Am J Kidney Dis 2010; 56: 817-819.
8. Poste G. Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards. Trends Mol Med 2012; 18: 717-722.
9. Sato M, Ohmori-Matsuda K, Saito T, et al. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant 2013; 32: 484-491.
10. Wheelock CE, Goss VM, Balgoma D, et al. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013; 42: 802-825.
11. Willner DL, Hugenholtz P, Yerkovich ST, et al. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2013; 187: 640-647.
12. Hutchinson JA, Riquelme P, Sawitzki B, et al. Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol 2011; 187: 2072-2078.
13. Nawrot TS, Vos R, Jacobs L, et al. The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation. Thorax 2011; 66: 748-754.
14. Billy F, Ribba B, Saut O, et al. A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy. J Theor Biol 2009; 260: 545-562.
15. Boissel JP, Ribba B, Grenier E, et al. Modelling methodology in physiopathology. Prog Biophys Mol Biol 2008; 97: 28-39.